ChemicalBook > Product Catalog >API >Antipyretic analgesics >Analgesics >Olorinab

Olorinab

Request For Quotation
Olorinab Suppliers list
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: Fan De(Beijing) Biotechnology Co., Ltd.  
Tel: 15911056312
Email: liming@bio-fount.com
Company Name: TargetMol Chemicals Inc.  
Tel: +1-781-999-5354; +1-00000000000
Email: marketing@targetmol.com
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD  
Tel: 86-571-88216897,88216896 13588875226
Email: sales@hzclap.com
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Email: sales@chemegen.com

Olorinab manufacturers

  • Olorinab
  • Olorinab pictures
  • $51.00
  • 2026-07-15
  • CAS:1268881-20-4
  • Purity: 97.67%
  • Supply Ability: 10g
  • Olorinab
  • Olorinab pictures
  • $51.00
  • 2026-07-15
  • CAS:1268881-20-4
  • Purity: 97.67%
  • Supply Ability: 10g
Olorinab Basic information
Product Name:Olorinab
Synonyms:Olorinab;1H-Cyclopropa[4,5]cyclopenta[1,2-c]pyrazole-3-carboxamide, 4,4a,5,5a-tetrahydro-N-[(1S)-1-(hydroxymethyl)-2,2-dimethylpropyl]-1-(4-oxido-2-pyrazinyl)-, (4aS,5aS)-;APD 371 - Bio-X;(2S,4S)-N-[(1S)-1-(hydroxymethyl)-2,2-dimethyl-propyl]-9-(4-oxidopyrazin-4-ium-2-yl)-8,9-diazatricyclo[4.3.0.02?]nona-1(6),7-diene-7-carboxamide;3-[(4aS,5aS)-3-[[(S)-1-Hydroxy-3,3-dimethyl-2-butyl]carbamoyl]-4,4a,5,5a-tetrahydro-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazol-1-yl]pyrazine 1-Oxide;3-((4aS,5aS)-3-(((S)-1-Hydroxy-3,3-dimethylbutan-2-yl)carbamoyl)-4,4a,5,5a-tetrahydro-1H-cyclopropa[4,5]cyclopenta[1,2-c]pyrazol-1-yl)pyrazine 1-oxide
CAS:1268881-20-4
MF:C18H23N5O3
MW:357.41
EINECS:
Product Categories:
Mol File:1268881-20-4.mol
Olorinab Structure
Olorinab Chemical Properties
Boiling point 636.6±55.0 °C(Predicted)
density 1.49±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility Chloroform (Slightly), Methanol (Slightly)
pka13.39±0.20(Predicted)
form Solid
color White to Off-White
Safety Information
MSDS Information
Olorinab Usage And Synthesis
UsesAPD371 is potent and selective Cannabinoid Receptor Type 2 (CB2) Agonist. It is orally available and has analgesic effects used as possible treatment to chronic pain.
in vivo

Olorinab (APD 371) significantly increases paw withdrawal thresholds at doses ≥3 mg/kg PO (ED50=2.3 mg/kg). In a separate experiment, a single dose of Olorinab (APD 371) (10 mg/kg, PO) inhibits paw withdrawal threshold for up to 4 hours after administration. Seperately, the analgesic effects of Olorinab (APD 371) are shown to be highly likely mediated via activity at CB2 receptors[1].
Tag:Olorinab(1268881-20-4) Related Product Information
N-[[[[(4S)-3-(4-Chlorophenyl)-4,5-dihydro-4-phenyl-1H-pyrazol-1-yl][[[4-(trifluoromethyl)phenyl]sulfonyl]amino]methylene]amino]iminomethyl]acetamide Pregnenolone Dehydroabietylamine Dehydroepiandrosteron(DHEA) AM 251 Linoleoylethanolamide